:quality(75)/dvgnzpfv30f28.cloudfront.net/12-14-2020/t_5e35a3a4c0344b72bd83a7b3499fea26_name_file_640x360_600_v3_.jpg)
Falla un medicamento de Novartis contra el COVID-19
El grupo farmacéutico suizo Novartis anunció el lunes que los ensayos clínicos con ruxolitinib no mostraron mejoras en casos severos de COVID-19. (Fuente: AFP)
- Redacción PERÚ21
- 14 de diciembre de 2020, 04:32 p.m.
- Duración: 00:59
:quality(75)/cdn.jwplayer.com/v2/media/OebjOQeV/poster.jpg)
:quality(75)/peru21.pe/resizer/citAJRLLrIV3YVN8rj51HjeNtfY=/314x0/smart/filters:format(jpeg):quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/3DMZCS3Y2RFIHE2K2EZ744OZMI.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/w7VbMHsY/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/je6jBIAo/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/TGZD64H6LVCNBDULBXDPBNUIAA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ECTTBTD3QFD55KGZSTDLIVP3QI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/CAICL7EHYRCLPEJN6U4IQ74J74.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/DXOA43KUD5G6NKDKRTVNU55TIU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/WOIVP6VDAFHR3EPGCWY4NHHZQI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/H3GKA6KUGJFOJDZSJMRZD3C3XA.png)
:quality(75)/cdn.jwplayer.com/v2/media/jzNsG03q/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/2YBY4U4WNBG6FJSXLUCH2M2HJA.png)